Key amino acids of vasopressin V1a receptor responsible for the species difference in the affinity of OPC-21268
-
Add time:07/21/2019 Source:sciencedirect.com
A non-peptide, vasopressin V1a receptor-selective antagonist, OPC-21268, exhibited a markedly higher affinity for the rat V1a receptor (Ki=380 nM) than for the human V1a receptor (Ki=140 μM). To delineate the region responsible for the high affinity binding of OPC-21268 for the rat V1a receptor, we have constructed a series of chimeric human and rat V1a receptors, and examined the chimeric and point-mutated receptors by competitive radioligand binding analysis. The results showed that the transmembrane domain (TMD) VI–VII of the vasopressin V1a receptor, in particular the amino acid residue Ala-342 in TMD VII, is the major component conferring the rat-selective binding of OPC-21268 to the V1a receptor.
We also recommend Trading Suppliers and Manufacturers of OPC 21268 (cas 131631-89-5). Pls Click Website Link as below: cas 131631-89-5 suppliers
Prev:Efficacies of quorum sensing inhibitors, piericidin A and glucopiericidin A, produced by Streptomyces xanthocidicus KPP01532 for the control of potato soft rot caused by Erwinia carotovora subsp. atroseptica
Next:Effects of the non-peptide inhibitor OPC-21268 on oxytocin and vasopressin stimulation of rat and human myometrium) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Distinct Mechanisms of Action of V1 Antagonists OPC-21268 and [d(CH2)5Tyr(Me)AVP] in Mesangial Cells07/28/2019
- Effects of OPC-21268, a vasopressin V1-receptor antagonist, on expression of growth factors from glomeruli in spontaneously hypertensive rats07/27/2019
- Effect of vasopressin V1 (OPC-21268) and V2 (OPC-31260) antagonists on renal hemodynamics and excretory function07/26/2019
- Effect of a new V1 antagonist (OPC-21268) on vascular action of vasopressin in cultured rat vascular smooth muscle cells07/25/2019
- The Role of Vasopressin in Essential Hypertension07/24/2019
- Synthesis of N-Acetylhemiaminal metabolites of opc-21268, vasopressin V1 receptor antagonist07/23/2019
- Effects of the non-peptide inhibitor OPC-21268 on oxytocin and vasopressin stimulation of rat and human myometrium07/22/2019


